Industry / Brazil
Cervical Cancer Programmes Receive Funding Boost
September 2011 | Industry Trend AnalysisBMI View: While most developed countries have incorporated some form of the human papillomavirus (HPV) vaccine into their national cervical cancer strategy, we believe Brazil's emphasis on public screening - not prevention - is driven by a desire to source a vaccine variant that is more suitable and cost effective to the country's healthcare needs.
To read the full article, please choose one of the following options:
Subcribers please log in




